China’s Uni-Bio Science, Luqa Pharmaceuticals ink deal for dermatology drug-device combos

Uni-Bio Science (HKG:0690) said today that it inked a strategic partnership with Luqa Pharmaceuticals for the marketing of dermatology drug-device combination products.

According to the agreement, the China-based companies can co-promote drugs or medical devices for the treatment of dermatological disorders, including existing products. The 3-year promotion agreement, with an option to renew for 2 more years, enables Uni-Bio Science to co-market particular products in hospitals and qualified institutions, drug stores and retail channels. Uni-Bio Science will support Luqa with market access in designated territories, including provincial and national reimbursement expansion of the products indicated under the collaboration.

Get the full story at our sister site, Drug Delivery Business News

 

 

The post China’s Uni-Bio Science, Luqa Pharmaceuticals ink deal for dermatology drug-device combos appeared first on MassDevice.

from MassDevice http://ift.tt/2fSxOeS